• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts.逆转双膦酸盐对原代人口腔成纤维细胞的细胞效应的新型疗法。
J Oral Maxillofac Surg. 2011 Oct;69(10):2564-78. doi: 10.1016/j.joms.2011.03.005. Epub 2011 Jul 31.
2
Inhibition of oral mucosal cell wound healing by bisphosphonates.双膦酸盐对口腔黏膜细胞伤口愈合的抑制作用。
J Oral Maxillofac Surg. 2008 May;66(5):839-47. doi: 10.1016/j.joms.2008.01.026.
3
The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study.双磷酸盐对人口腔角质细胞活力、迁移和凋亡的影响——体外研究。
Clin Oral Investig. 2012 Feb;16(1):87-93. doi: 10.1007/s00784-010-0507-6. Epub 2011 Jan 12.
4
The influence of geranylgeraniol on human oral keratinocytes after bisphosphonate treatment: An in vitro study.香叶基香叶醇对双膦酸盐治疗后人口腔角质形成细胞的影响:一项体外研究。
J Craniomaxillofac Surg. 2015 Jun;43(5):688-95. doi: 10.1016/j.jcms.2015.03.014. Epub 2015 Mar 27.
5
Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro.双膦酸盐在体外影响 HUVEC、成纤维细胞和骨细胞的迁移能力和细胞活力。
Oral Dis. 2011 Mar;17(2):194-9. doi: 10.1111/j.1601-0825.2010.01720.x. Epub 2010 Aug 27.
6
Bisphosphonates inhibit cell functions of HUVECs, fibroblasts and osteogenic cells via inhibition of protein geranylgeranylation.双膦酸盐通过抑制蛋白质香叶基香叶基化来抑制人脐静脉内皮细胞、成纤维细胞和成骨细胞的细胞功能。
Clin Oral Investig. 2015 Jun;19(5):1079-91. doi: 10.1007/s00784-014-1320-4. Epub 2014 Sep 27.
7
Effects of pamidronate on human alveolar osteoblasts in vitro.帕米膦酸盐对人牙槽成骨细胞的体外作用。
J Oral Maxillofac Surg. 2012 May;70(5):1081-92. doi: 10.1016/j.joms.2011.05.002.
8
The influence of geranylgeraniol on microvessel sprouting after bisphosphonate substitution in an in vitro 3D-angiogenesis assay.在体外三维血管生成试验中,香叶基香叶醇对双膦酸盐替代后微血管芽生的影响。
Clin Oral Investig. 2017 Apr;21(3):771-778. doi: 10.1007/s00784-016-1842-z. Epub 2016 May 12.
9
Zoledronic acid and geranylgeraniol regulate cellular behaviour and angiogenic gene expression in human gingival fibroblasts.唑来膦酸和香叶基香叶醇调节人牙龈成纤维细胞的细胞行为和血管生成基因表达。
J Oral Pathol Med. 2014 Oct;43(9):711-21. doi: 10.1111/jop.12181. Epub 2014 Apr 25.
10
Comments on Novel Therapy to Reverse the Cellular Effects of Bisphosphonates on Primary Human Oral Fibroblasts by Cozin M et al (2011).科津等人(2011年)对新型疗法逆转双膦酸盐对原代人口腔成纤维细胞的细胞效应的评论
J Oral Maxillofac Surg. 2012 Jan;70(1):3. doi: 10.1016/j.joms.2011.10.021.

引用本文的文献

1
Geranylgeraniol (GGOH), incorporated into a bone cement pellet promotes osteoclast function and healing in a model of medication-related osteonecrosis of the jaw.香叶基香叶醇(GGOH)掺入骨水泥微丸中,可促进颌骨药物相关性骨坏死模型中的破骨细胞功能和愈合。
J Oral Biol Craniofac Res. 2024 Mar-Apr;14(2):126-132. doi: 10.1016/j.jobcr.2024.01.014. Epub 2024 Feb 1.
2
In Vitro Cytotoxicity of Antiresorptive and Antiangiogenic Compounds on Oral Tissues Contributing to MRONJ: Systematic Review.抗吸收和抗血管生成化合物对口腔组织的体外细胞毒性与 MRONJ 有关:系统评价。
Biomolecules. 2023 Jun 10;13(6):973. doi: 10.3390/biom13060973.
3
Bisphosphonate affects the behavioral responses to HCl by disrupting farnesyl diphosphate synthase in mouse taste bud and tongue epithelial cells.双膦酸盐通过破坏法呢基二磷酸合酶在小鼠味蕾和舌上皮细胞中的作用来影响 HCl 的行为反应。
Sci Rep. 2022 Dec 8;12(1):21246. doi: 10.1038/s41598-022-25755-5.
4
Effect of Geranylgeraniol (GGOH) on Bisphosphonate-Induced Cytotoxicity of Oral Mucosa Cells.香叶基香叶醇(GGOH)对双膦酸盐诱导的口腔黏膜细胞毒性的影响。
Front Oral Health. 2022 Jun 20;3:892615. doi: 10.3389/froh.2022.892615. eCollection 2022.
5
The Role of Geranylgeraniol in Managing Bisphosphonate-Related Osteonecrosis of the Jaw.香叶基香叶醇在治疗双膦酸盐相关颌骨坏死中的作用。
Front Pharmacol. 2022 May 4;13:878556. doi: 10.3389/fphar.2022.878556. eCollection 2022.
6
A Review Into the Effects of Pamidronic Acid and Zoledronic Acid on the Oral Mucosa in Medication-Related Osteonecrosis of the Jaw.帕米膦酸和唑来膦酸对颌骨药物相关性骨坏死口腔黏膜影响的综述
Front Oral Health. 2022 Feb 9;2:822411. doi: 10.3389/froh.2021.822411. eCollection 2021.
7
Characterization of Mesenchymal Stem Cells Derived from Bisphosphonate-Related Osteonecrosis of the Jaw Patients' Gingiva.来源于双膦酸盐相关性颌骨骨坏死患者牙龈的间充质干细胞的特征。
Stem Cell Rev Rep. 2022 Jan;18(1):378-394. doi: 10.1007/s12015-021-10241-8. Epub 2021 Sep 22.
8
Geranyl-geraniol addition affects potency of bisphosphonates-a comparison in vitro promising a therapeutic approach for bisphosphonate-associated osteonecrosis of the jaw and oral wound healing.香叶基香叶醇加成影响双膦酸盐的效力——体外比较有望为双膦酸盐相关性颌骨坏死和口腔伤口愈合提供一种治疗方法。
Oral Maxillofac Surg. 2022 Jun;26(2):321-332. doi: 10.1007/s10006-021-00982-8. Epub 2021 Aug 15.
9
Standardized Extract Shows Cytoprotective Effects in Zoledronic Acid-Treated Fibroblasts and Osteoblasts.标准化提取物在唑来膦酸处理的成纤维细胞和成骨细胞中显示出细胞保护作用。
Clin Cosmet Investig Dent. 2020 Aug 11;12:327-333. doi: 10.2147/CCIDE.S259158. eCollection 2020.
10
Synthetic Hydroxyapatite Inhibits Bisphosphonate Toxicity to the Oral Mucosa In Vitro.合成羟基磷灰石在体外抑制双膦酸盐对口腔黏膜的毒性。
Materials (Basel). 2020 May 1;13(9):2086. doi: 10.3390/ma13092086.

本文引用的文献

1
Potential pathophysiological mechanisms in osteonecrosis of the jaw.颌骨骨坏死的潜在病理生理学机制。
Ann N Y Acad Sci. 2011 Feb;1218:62-79. doi: 10.1111/j.1749-6632.2010.05835.x.
2
Bisphosphonate effects on the behaviour of oral epithelial cells and oral fibroblasts.双膦酸盐对口腔上皮细胞和口腔成纤维细胞行为的影响。
Arch Oral Biol. 2011 May;56(5):491-8. doi: 10.1016/j.archoralbio.2010.11.003. Epub 2010 Dec 10.
3
Anticancer properties of zoledronic acid.唑来膦酸的抗癌特性。
Cancer Invest. 2010 Nov;28(9):944-57. doi: 10.3109/07357907.2010.512598.
4
Bisphosphonate osteonecrosis of the jaw--a literature review of UK policies versus international policies on bisphosphonates, risk factors and prevention.双膦酸盐相关性颌骨坏死——关于英国双膦酸盐政策与国际政策、风险因素及预防的文献综述
Br J Oral Maxillofac Surg. 2011 Jun;49(4):251-7. doi: 10.1016/j.bjoms.2010.05.007. Epub 2010 Jun 7.
5
Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons.双膦酸盐相关性颌骨坏死:来自日本骨矿研究学会联合工作组委员会、日本骨质疏松症学会、日本牙周病学会、日本口腔颌面放射学会和日本口腔颌面外科学会的立场文件。
J Bone Miner Metab. 2010 Jul;28(4):365-83. doi: 10.1007/s00774-010-0162-7. Epub 2010 Mar 24.
6
Is zoledronate toxic to human periodontal fibroblasts?唑来膦酸是否对人牙周成纤维细胞有毒性?
J Dent Res. 2010 Jan;89(1):40-5. doi: 10.1177/0022034509354298.
7
American Association of Oral and Maxillofacial Surgeons position paper: Bisphosphonate-Related Osteonecrosis of the Jaws-2009 update: the need to refine the BRONJ definition.美国口腔颌面外科医师协会立场文件:双膦酸盐相关颌骨坏死-2009年更新:完善BRONJ定义的必要性
J Oral Maxillofac Surg. 2009 Dec;67(12):2698-9. doi: 10.1016/j.joms.2009.07.097.
8
Pre-clinical models for oral and periodontal reconstructive therapies.口腔及牙周重建治疗的临床前模型
J Dent Res. 2009 Dec;88(12):1065-76. doi: 10.1177/0022034509349748. Epub 2009 Nov 3.
9
Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients.双膦酸盐相关颌骨坏死:26例患者的临床特征、危险因素、管理及治疗结果
J Oral Maxillofac Surg. 2009 Sep;67(9):1904-13. doi: 10.1016/j.joms.2009.04.051.
10
Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk.颌骨骨坏死与双膦酸盐相关:34 例病例回顾与风险评估
J Craniomaxillofac Surg. 2010 Jun;38(4):255-9. doi: 10.1016/j.jcms.2009.06.005. Epub 2009 Jul 9.

逆转双膦酸盐对原代人口腔成纤维细胞的细胞效应的新型疗法。

Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts.

作者信息

Cozin Matthew, Pinker Bradley M, Solemani Kimberley, Zuniga Jeremy M, Dadaian Stephen C, Cremers Serge, Landesberg Regina, Raghavan Srikala

机构信息

College of Dental Medicine, Columbia University, New York, NY 10032, USA.

出版信息

J Oral Maxillofac Surg. 2011 Oct;69(10):2564-78. doi: 10.1016/j.joms.2011.03.005. Epub 2011 Jul 31.

DOI:10.1016/j.joms.2011.03.005
PMID:21807448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3179815/
Abstract

PURPOSE

Osteonecrosis of the jaws (ONJ) is a clinical condition that is characterized by a nonhealing breach in the oral mucosa resulting in exposure of bone and has been increasingly reported in patients receiving bisphosphonate (BP) therapy. Although the pathogenesis and natural history of ONJ remain ill-defined, it appears that the oral soft tissues play a critical role in the development of this condition. We examined the effects of the nitrogen-containing BPs pamidronate and zoledronate on primary human gingival fibroblasts.

MATERIALS AND METHODS

Primary gingival fibroblasts were exposed to clinically relevant doses of pamidronate and zoledronate. Cellular proliferation was measured with an MTS/PMS reagent-based kit (Promega, Madison, WI), scratch wound assays were performed to measure cellular migration, and apoptosis was measured by use of terminal deoxynucleotidyl transferase-mediated dUTP-FITC end labeling and caspase assays. The BP-exposed cells were treated with 10-ng/mL recombinant human platelet-derived growth factor BB (rhPDGF-BB) and 50-μmol/L geranylgeraniol (GGOH).

RESULTS

Gingival fibroblasts are significantly more sensitive to inhibition of proliferation by zoledronate compared with pamidronate. Exposure of these cells to pamidronate but not zoledronate resulted in an increase in cellular apoptosis. Furthermore, exposure of gingival fibroblasts to pamidronate or zoledronate resulted in a decrease in cellular migration. We show that these defects are due to a loss of cell-substratum adhesion and a reduction of F-actin bundles. Finally, we show that the addition of rhPDGF-BB and GGOH in vitro is able to partially rescue the cell proliferation, migration, and adhesion defects.

CONCLUSION

The cytotoxic effects of BPs on oral fibroblasts and their significant reversal by the addition of GGOH and rhPDGF-BB provide both the potential mechanism and treatment options for ONJ.

摘要

目的

颌骨骨坏死(ONJ)是一种临床病症,其特征为口腔黏膜出现不愈合的创口,导致骨暴露,且接受双膦酸盐(BP)治疗的患者中该病症的报告日益增多。尽管ONJ的发病机制和自然病程仍不明确,但口腔软组织似乎在该病症的发展中起关键作用。我们研究了含氮双膦酸盐帕米膦酸盐和唑来膦酸盐对原代人牙龈成纤维细胞的影响。

材料与方法

将原代牙龈成纤维细胞暴露于临床相关剂量的帕米膦酸盐和唑来膦酸盐。使用基于MTS/PMS试剂的试剂盒(Promega,麦迪逊,威斯康星州)测量细胞增殖,进行划痕伤口试验以测量细胞迁移,并通过末端脱氧核苷酸转移酶介导的dUTP-FITC末端标记和半胱天冬酶试验测量细胞凋亡。用10 ng/mL重组人血小板衍生生长因子BB(rhPDGF-BB)和50 μmol/L香叶基香叶醇(GGOH)处理暴露于BP的细胞。

结果

与帕米膦酸盐相比,牙龈成纤维细胞对唑来膦酸盐抑制增殖的敏感性明显更高。这些细胞暴露于帕米膦酸盐而非唑来膦酸盐会导致细胞凋亡增加。此外,牙龈成纤维细胞暴露于帕米膦酸盐或唑来膦酸盐会导致细胞迁移减少。我们表明这些缺陷是由于细胞与基质的粘附丧失和F-肌动蛋白束减少所致。最后,我们表明在体外添加rhPDGF-BB和GGOH能够部分挽救细胞增殖、迁移和粘附缺陷。

结论

双膦酸盐对口腔成纤维细胞的细胞毒性作用以及添加GGOH和rhPDGF-BB对其的显著逆转,为ONJ提供了潜在的发病机制和治疗选择。